Pharmaniaga Bhd (7081) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.042x

Based on the latest financial reports, Pharmaniaga Bhd (7081) has a cash flow conversion efficiency ratio of -0.042x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-20.78 Million ≈ $-5.22 Million USD) by net assets (RM489.50 Million ≈ $122.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View 7081 stock price and chart for real-time trading data and today's change.

Pharmaniaga Bhd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Pharmaniaga Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Pharmaniaga Bhd (7081) market capitalisation for the company's overall valuation and market capitalisation.

Pharmaniaga Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmaniaga Bhd ranked by their cash flow conversion efficiency. Also see Pharmaniaga Bhd asset portfolio for a full breakdown of the balance sheet.

Company Cash Flow Conversion Efficiency
First Bancorp Inc
NASDAQ:FNLC
0.078x
Nanjing Aolian Ae&Ea Co Ltd
SHE:300585
0.027x
The Anup Engineering Limited
NSE:ANUP
-0.098x
Enseval Putra Megatrading Tbk
JK:EPMT
0.035x
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
-0.099x
GDI Integrated
TO:GDI
0.066x
K & S Corporation Ltd
AU:KSC
0.075x
Lux Industries Limited
NSE:LUXIND
-0.130x

Annual Cash Flow Conversion Efficiency for Pharmaniaga Bhd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Pharmaniaga Bhd from 2012 to 2025. Review Pharmaniaga Bhd (7081) financial flexibility to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 RM459.15 Million
≈ $115.28 Million
RM-17.69 Million
≈ $-4.44 Million
-0.039x +86.82%
2024-12-31 RM-145.94 Million
≈ $-36.64 Million
RM42.67 Million
≈ $10.71 Million
-0.292x -70.67%
2023-12-31 RM-274.09 Million
≈ $-68.81 Million
RM46.95 Million
≈ $11.79 Million
-0.171x -141.92%
2022-12-31 RM-348.31 Million
≈ $-87.45 Million
RM-142.34 Million
≈ $-35.74 Million
0.409x +400.12%
2021-12-31 RM470.44 Million
≈ $118.11 Million
RM-64.06 Million
≈ $-16.08 Million
-0.136x -78.76%
2020-12-31 RM337.53 Million
≈ $84.74 Million
RM-25.71 Million
≈ $-6.45 Million
-0.076x -113.56%
2019-12-31 RM337.85 Million
≈ $84.82 Million
RM189.76 Million
≈ $47.64 Million
0.562x +449.59%
2018-12-31 RM509.34 Million
≈ $127.88 Million
RM-81.83 Million
≈ $-20.55 Million
-0.161x -135.44%
2017-12-31 RM528.05 Million
≈ $132.57 Million
RM239.41 Million
≈ $60.11 Million
0.453x +578.93%
2016-12-31 RM530.63 Million
≈ $133.22 Million
RM35.44 Million
≈ $8.90 Million
0.067x +434.25%
2015-12-31 RM560.00 Million
≈ $140.60 Million
RM7.00 Million
≈ $1.76 Million
0.013x -96.76%
2014-12-31 RM552.00 Million
≈ $138.59 Million
RM213.00 Million
≈ $53.48 Million
0.386x -23.89%
2013-12-31 RM503.00 Million
≈ $126.29 Million
RM255.00 Million
≈ $64.02 Million
0.507x +1355.27%
2012-12-31 RM488.00 Million
≈ $122.52 Million
RM17.00 Million
≈ $4.27 Million
0.035x --

About Pharmaniaga Bhd

KLSE:7081 Malaysia Medical Distribution
Market Cap
$391.81 Million
RM1.56 Billion MYR
Market Cap Rank
#13624 Global
#148 in Malaysia
Share Price
RM1.19
Change (1 day)
+0.00%
52-Week Range
RM0.17 - RM1.38
All Time High
RM1.38
About

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more